www.pharmacoreport .com is a news site providing information
about the top international pharmaceutical companies. This
website will also provide other information about these
pharmaceuticals like their address and locations, corporate
history, clinical trials, annual report, employees, careers and
jobs, health care products, research, sales, shares, dividend &
stock price, and patients’ assistance program.
Sanofi-Aventis has secured and maintained the position amongst the five biggest pharmaceuticals companies of the world that also include pharmaceutical giants like Pfizer, Bristol-Myer Squibb, Novartis and GlaxoSmithKline. The company is having it’s headquarter located in Paris, France and is engaged in consistent researching, developing, producing and commercializing of the different pharmaceutical products mainly in the prescription market segments. Moreover, the company also offers several products for sale under the OTC segments. Sanofi-Aventis including its subsidiary Sanofi-Pasteur has included 7 essential therapeutic sectors such as: cardiovascular, thrombosis, oncology, diabetes, central nervous system-CNS, internal medications and different vaccines.
The entity of Sanofi-Aventis was constituted sometimes during 2004 following Sanofi-Synthelabo duly amalgamated with Aventis when it made the aggressive takeover bid worth € 47.8 billion against Aventis. Sanofi-Synthelabo was formed in 1999 when Sanofi [which was the subsidiary of Total, earlier] amalgamated with Synthelabo [former subsidiary of L’Oreal] and this amalgamated company was located in Paris, France.
Aventis was shaped up during 1999 when Rhone-Poulenc S.A. amalgamated with Hoechst Marion Roussel which was constituted following the unification of Hoechst AG and Roussel Uclaf and Marion Merrell Dow. This new unified company was situated at Schiltigheim, near Strasbourg in France.
Sanofi-Aventis offers different medications for the treating the patients of several therapeutic sectors like: cardiovascular ailments, thrombosis related ailments, metabolic disorders, oncology diseases, central nervous system-CNS related disorders, several internal medications and different types of vaccines for preventing various diseases.
Some of the major and popular products of this company include: Lasix, Amaryl, Taxotere, Allegra, Rabipur, Frisium, Plavix, Cordarone, Stilnoct, Primacor IV, Valparin and Myoril.
To bet on the result of the attempts, is all in a dayand work for your average pharmaceutical investor. It takes a more critical dimension with notice to at.....More
Is Bristol-Myers ripe for takeover?
To name through the FAILURE a permanent successor to its relieved general director, Bristol-Myers Squibb Co may signal. that it is for sale for the correct price, have analyst gesagt...More
FDA Advisory Committee Recommends Licensure of New Pediatric Combinati...
,), Is selected delighted that the members of an adviser to the USA food and drug administration (FDA) nearly unanimously today that the companyand....More
Sanofi-Aventis in pact with Prasco to market generic Allegra version...
PARIS (AFX) - Sanofi-Aventis said that its Aventis has signs pharmaceutical unit a distribution and provision agreement with Prasco Laboren to shoot down a, .....More
Euroshares open higher after Wall St gains; Sanofi-Aventis rebounds
LONDON (AFX) - shares on Europeand, that bourses leads, opened ahead following profits over USA of markets yesterday, and with profits in Sanofi-Aventis after.....More
A Killer Virus Spreads - Forbes.com
That left Sanofi-Aventis as a the single approved grippegeschossene supplier. GlaxoSmithKline (nyse: GSK - messages - of people), a head producer of flus shots on board, .....More
On the Move: Philips, Vodafone, Sanofi-Aventis
Sanofi-Aventis (SNY) was down â ‚¬1.00 to â ‚¬75.15. an USA tribunal has against the firm and the partner QLT of Canada in a case around its Eligard drug reigns, .....More
PARIS (AFX) - Sanofi-Aventis said, that initiating results of a vorreichlich vaccine for the H5N1 load of bird flu, with andgood of immune answer ermutigten...More
Sanofi-Aventis says tribunal has rejected Rhodia& compensation...
PARIS (AFX) - Sanofi-Aventis said that the arbitration procedure tribunal a claim of Rhodia, a firm rejected, that was spun from of Aventis of that, compensation sought.....More
Sanofi-Aventis signs partnership for developing Dengue fever vaccine
PARIS (AFX) - Sanofi-Aventis said that its Sanofi Pasteur unit has signs a partnership with the pediatric Denguefieber vaccine initiative to develop and to produce to help.....More
Enquiry
Field Marked with asterisk (*) are mandatory
Name *
Email *
State/Country
Comments *
Most of the pharmaceuticals co manufacturing and r&d locations are in USA, UK, France, India, China, Australia, Canada, Ireland, Malaysia, Singapore and NJ – US. This website is for information only and not meant for any medical or health advice. Some of the information and the news might be outdated as of today.
